4.6 Review

Live-Animal Epigenome Editing: Convergence of Novel Techniques

Journal

TRENDS IN GENETICS
Volume 35, Issue 7, Pages 527-541

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tig.2019.04.007

Keywords

-

Funding

  1. NIH [T32CA108459]
  2. DOD [W81XWH-17-1-0200]
  3. Foundation for Angelman Syndrome Therapeutics

Ask authors/readers for more resources

Epigenome editing refers to the generation of precise chromatin alterations and their effects on gene expression and cell biology. Until recently, much of the efforts in epigenome editing were limited to tissue culture models of disease. However, the convergence of techniques from different fields including mammalian genetics, virology, and CRISPR engineering is advancing epigenome editing into a new era. Researchers are increasingly embracing the use of multicellular model organisms to test the role of specific chromatin alterations in development and disease. The challenge of successful live-animal epigenomic editing will depend on a well-informed foundation of the current methodologies for cell-specific delivery and editing accuracy. Here we review the opportunities for basic research and therapeutic applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available